Immunological evaluation of patients with orthopedic infections: taking the Cierny–Mader classification to the next level
<p><strong>Introduction</strong>: Cierny–Mader osteomyelitis classification is used to label A, B, or C hosts based on comorbidities. This study's purpose was to define the “true” host status of patients with orthopedic infection using serologic markers to quantify the compete...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Copernicus Publications
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cbea882304524883a36d0942185227a4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p><strong>Introduction</strong>: Cierny–Mader osteomyelitis classification is used to label A, B, or C hosts based on comorbidities. This study's purpose was to define the “true” host status of patients with
orthopedic infection using serologic markers to quantify the competence of their immune system while actively infected. <strong>Methods</strong>: Retrospective
chart review identified patients at a single-surgeon practice who were
diagnosed with orthopedic infection between September 2013 and March 2020 and had immunological laboratory results. All patients were A or B hosts who
underwent surgery to eradicate infection. Medical history, physical
examination, and Cierny–Mader classification were recorded. Laboratory results included complement total, C3, C4, immunoglobulin G (IgG), immunoglobulin M (IgM), immunoglobulin A (IgA), immunoglobulin E (IgE), rheumatoid factor, and antineutrophil cytoplasmic antibodies (ANCA) panel. Clinically significant results were defined as flagged abnormal. Normal complement levels and normal IgG levels were
considered abnormal when infection was present. <strong>Results</strong>: Of 105
patients, 99 (94 %) had documented lab abnormalities. Clinically
significant abnormalities were found in 33 of 34 (97 %) type-A hosts and 66 of 71 (93 %) type-B hosts. Eleven of 105 (10.5 %) patients were formally diagnosed with primary immunodeficiency by a hematologist. IgG deficiency,
of either low or normal value, in the face of infection comprised 91 % (30 of 34) type-A hosts and 86 % (56 of 71) type-B hosts. Six (5.7 %) patients received IgG replacement therapy. Twenty-eight patients had abnormal total complement levels (low or normal): 7.4 % (2 of 34) A hosts and 40 % (26 of 71) B hosts (<span class="inline-formula"><i>p</i>=0.002</span>). B hosts had statistically significantly
lower complement levels and significantly more no-growth cultures (<span class="inline-formula"><i>p</i><0.03</span>). Thirteen of 14 patients with recurrent infections had low
or normal IgG levels. IgM was significantly lower between reinfected patients and those without reinfection (<span class="inline-formula"><i>p</i>=0.0005</span>). <strong>Conclusions</strong>:
Adding immunologic evaluation to the Cierny–Mader classification more accurately determines patients' true host status and better quantifies risk
and outcome with respect to orthopedic infection. Immunologically deficient A hosts should be quantified as B hosts. IgG deficiencies may be
addressed when deemed appropriate by the consulting
hematologist/immunologist. Patients with recurrent infections had
significantly lower IgM levels than their nonrecurrent infection
counterparts.</p> |
|---|